Enrico Caliman

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 117 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

David J. Pinato, Daniela Ferrante, Georgina Hanbury et al. · The Lancet Oncology · 2022 · 80 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Luca Cantini, Giulia Mentrasti, Gian Luigi Russo et al. · ESMO Open · 2022 · 65 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study

Agnese Paderi, Sara Fancelli, Enrico Caliman et al. · Current Oncology · 2021 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy

Enrico Caliman, Sara Fancelli, Carlotta Ottanelli et al. · Cancer Treatment and Research Communications · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17